Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07434986 · ClinicalTrials.gov registry record · NA
Overnight TI in TLE
A NA study, sponsored by Duke University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07434986 is a NA study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 20 participants.
The verdict
NCT07434986, a NA study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to gauge whether overnight, non-invasive temporal interference (TI) stimulation aimed at the hippocampus can reduce abnormal brain activity linked to seizures and improve sleep in adults with drug-resistant temporal lobe epilepsy. The main questions are: Does overnight TI stimulation lower seizure-related EEG activity during sleep? Does overnight TI stimulation improve sleep quality and sleep patterns measured overnight in the lab? Researchers will compare each participant's nights without stimulation to nights with active stimulation, and will also look at a night after stimulation ends to see whether any changes last. Participants will: Stay in-lab for six days for overnight sleep and EEG monitoring Have one night of monitoring without stimulation Receive TI stimulation during sleep for several nights Have another night of monitoring without stimulation after the stimulation nights Complete brief questionnaires and thinking/memory tasks before and after the stimulation nights Be checked for side effects and comfort during the study and at follow-up
Interventions
- DEVICE Non-invasive Temporal Interference (TI) Stimulation Targeting Bilateral Hippocampi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07434986
The ClinicalTrials.gov registry entry for NCT07434986 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive Temporal Interference (TI) Stimulation Targeting Bilateral Hippocampi is the first listed.
NCT07434986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07434986 about?
NCT07434986 is a clinical study titled "Overnight TI in TLE". The goal of this clinical trial is to gauge whether overnight, non-invasive temporal interference (TI) stimulation aimed at the hippocampus can reduce abnormal brain activity linked to seizures and improve sleep in adults with drug-resistant temporal lobe epilepsy. The main questions are: Does over...
What is the current status of trial NCT07434986?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06-01. Estimated completion is 2026-10-30.
What interventions are being tested in trial NCT07434986?
The interventions under investigation include: Non-invasive Temporal Interference (TI) Stimulation Targeting Bilateral Hippocampi (DEVICE).
Who is sponsoring clinical trial NCT07434986?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.